HEALTHGUARDIAN US
My son has cancer. Kalshi wants you to be able to bet on his medical future | Joshua Pederson
The author's 12-year-old son has an aggressive tumor near his heart, and Kalshi, a prediction market, is considering allowing bets on clinical trial results and regulatory decisions related to his treatment. The author, Joshua Pederson, is a professor at Boston University.
Mentioned
Related Signal
Adjacent reporting
- Can a Betting Market Offer Hope to a Cancer Patient?
- ‘Research here is world class’: son of Steve Jobs looks to invest in UK cancer care
- STAT+: Scientists link boy’s tumor to gene therapy viruses, in rare finding
- STAT+: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals